Point72 Asset Management L.P. Purchases 1,216,263 Shares of Select Medical Holdings Co. (NYSE:SEM)

Point72 Asset Management L.P. increased its position in Select Medical Holdings Co. (NYSE:SEMFree Report) by 144.2% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,059,791 shares of the health services provider’s stock after purchasing an additional 1,216,263 shares during the period. Point72 Asset Management L.P. owned approximately 1.59% of Select Medical worth $71,825,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Janus Henderson Group PLC lifted its stake in shares of Select Medical by 14.7% in the 3rd quarter. Janus Henderson Group PLC now owns 54,021 shares of the health services provider’s stock worth $1,883,000 after purchasing an additional 6,922 shares during the period. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Select Medical in the 3rd quarter worth approximately $290,000. BNP Paribas Financial Markets lifted its stake in shares of Select Medical by 141.0% in the 3rd quarter. BNP Paribas Financial Markets now owns 26,720 shares of the health services provider’s stock worth $932,000 after purchasing an additional 15,635 shares during the period. Quantbot Technologies LP bought a new position in shares of Select Medical in the 3rd quarter worth approximately $232,000. Finally, Loomis Sayles & Co. L P bought a new position in shares of Select Medical in the 3rd quarter worth approximately $9,710,000. Institutional investors own 89.48% of the company’s stock.

Select Medical Trading Down 0.2 %

Select Medical stock opened at $20.52 on Thursday. The stock has a market cap of $2.66 billion, a P/E ratio of 9.59, a PEG ratio of 0.41 and a beta of 1.43. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13. Select Medical Holdings Co. has a 1 year low of $19.82 and a 1 year high of $40.98. The firm’s 50 day moving average price is $33.24 and its 200-day moving average price is $34.43.

Select Medical (NYSE:SEMGet Free Report) last released its quarterly earnings data on Thursday, October 31st. The health services provider reported $0.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.07. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The firm had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.74 billion. During the same quarter last year, the business posted $0.46 earnings per share. The company’s revenue for the quarter was up 5.7% compared to the same quarter last year. On average, equities analysts predict that Select Medical Holdings Co. will post 1.97 earnings per share for the current fiscal year.

Select Medical Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Wednesday, November 13th were given a $0.125 dividend. This represents a $0.50 annualized dividend and a yield of 2.44%. The ex-dividend date of this dividend was Wednesday, November 13th. Select Medical’s dividend payout ratio is presently 23.36%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the stock. Royal Bank of Canada increased their target price on shares of Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a report on Monday, November 4th. Bank of America assumed coverage on shares of Select Medical in a report on Tuesday, August 20th. They issued a “buy” rating and a $42.00 target price for the company. Benchmark lowered shares of Select Medical from a “buy” rating to a “hold” rating in a report on Monday, November 25th. Finally, StockNews.com raised shares of Select Medical from a “hold” rating to a “buy” rating in a report on Tuesday.

View Our Latest Report on SEM

Insider Buying and Selling

In other Select Medical news, Director Marilyn B. Tavenner sold 32,000 shares of Select Medical stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total transaction of $674,880.00. Following the completion of the transaction, the director now directly owns 22,000 shares of the company’s stock, valued at $463,980. The trade was a 59.26 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 19.14% of the stock is currently owned by company insiders.

Select Medical Company Profile

(Free Report)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

Read More

Institutional Ownership by Quarter for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.